W05-02: Therapeutic Indications and Other Use-case-driven Updates in the Drug Ontology
|Title||W05-02: Therapeutic Indications and Other Use-case-driven Updates in the Drug Ontology|
|Publication Type||Conference Paper|
|Year of Publication||2016|
|Authors||Hogan WR, Hanna J, Hicks A, Amirova S, Bramblett B, Diller M, Enderez R, Modzelewski T, Vasconcelos M, Delcher C|
|Conference Name||International Conference on Biomedical Ontology and BioCreative (ICBO BioCreative 2016)|
|Publisher||CEUR-ws.org Volume 1747|
The Drug Ontology (DrOn) is a an OWL2-based representation of drug products and their ingredients, mechanisms of action, strengths, and dose forms, as well as of packaged drug products as represented by United States National Drug Codes (NDCs) [1-3]. The primary goal of DrOn is to support analyses of large, drug-related datasets such as pharmacy claims and EHR data.